We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,988
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.78%
2 Healthcare 3.27%
3 Industrials 2.02%
4 Financials 2.02%
5 Consumer Discretionary 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCRD
8751
DELISTED
CoreCard
CCRD
$333K ﹤0.01%
8,297
-1,085
-12% -$42.8K
MERC icon
8752
Mercer International
MERC
$31.6M
$333K ﹤0.01%
32,531
-5,355
-14% -$42.8K
MARK
8753
CALL
DELISTED
Remark Holdings, Inc.
MARK
$333K ﹤0.01%
17,510
-7,390
-30% -$101K
AVTA
8754
CALL
DELISTED
Avantax, Inc. Common Stock
AVTA
$333K ﹤0.01%
20,900
-24,800
-54% -$303K
BPMP
8755
CALL
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
$333K ﹤0.01%
31,400
+15,900
+103% +$166K
LMRK
8756
PUT
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
$333K ﹤0.01%
31,100
+7,300
+31% +$76.8K
PBE icon
8757
Invesco Biotechnology & Genome ETF
PBE
$357M
$332K ﹤0.01%
4,730
-26,767
-85% -$1.69M
VICR icon
8758
PUT
Vicor
VICR
$10.8B
$332K ﹤0.01%
3,600
-11,600
-76% -$974K
MODN
8759
PUT
DELISTED
MODEL N, INC.
MODN
$332K ﹤0.01%
9,300
-3,100
-25% -$107K
MSP
8760
CALL
DELISTED
Datto Holding Corp.
MSP
$332K ﹤0.01%
+12,300
New +$349K
BSET icon
8761
Bassett Furniture
BSET
$166M
$331K ﹤0.01%
+16,473
New +$278K
DVAX
8762
PUT
DELISTED
Dynavax Technologies
DVAX
$331K ﹤0.01%
74,300
-18,200
-20% -$82.4K
EYE icon
8763
CALL
National Vision
EYE
$1.53B
$331K ﹤0.01%
7,300
-10,800
-60% -$470K
TGB
8764
Trekor Metals
TGB
$3.06B
$331K ﹤0.01%
250,904
-13,352
-5% -$14.1K
UGP icon
8765
Ultrapar
UGP
$6.56B
$331K ﹤0.01%
73,077
+2,909
+4% +$11K
CNST
8766
CALL
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$331K ﹤0.01%
+11,500
New +$289K
WDR
8767
PUT
DELISTED
Waddell & Reed Financial, Inc.
WDR
$331K ﹤0.01%
13,000
-7,700
-37% -$148K
CPI
8768
DELISTED
CPI Inflation Hedged ETF
CPI
$331K ﹤0.01%
12,140
+16
+0.1% +$438
OSW icon
8769
CALL
OneSpaWorld
OSW
$2.73B
$330K ﹤0.01%
32,500
+8,900
+38% +$70.3K
UBX
8770
PUT
DELISTED
Unity Biotechnology
UBX
$330K ﹤0.01%
6,290
-1,630
-21% -$78.6K
VRDN icon
8771
Viridian Therapeutics
VRDN
$2.5B
$330K ﹤0.01%
20,040
+9,032
+82% +$136K
AEG icon
8772
Aegon
AEG
$14B
$329K ﹤0.01%
+90,321
New +$276K
AHT
8773
Ashford Hospitality Trust
AHT
$20.8M
$329K ﹤0.01%
+1,269
New +$323K
AROW icon
8774
Arrow Financial
AROW
$727M
$329K ﹤0.01%
+12,010
New +$319K
BJAN icon
8775
Innovator US Equity Buffer ETF January
BJAN
$349M
$329K ﹤0.01%
+10,040
New +$316K

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.